Bulletin
Calcium Chloride Injection
03 November 2008
Products Affected - Description
100 mg/mL 10 mL vials (NDC 63323-0114-10), APP (American Pharmaceutical Partners, formerly Abraxis) - discontinued
Reason for the Shortage
- APP was holding distribution of calcium chloride injection due to regulatory difficulties.
- American Regent's product was in short supply due to an increased demand.
- Hospira would not provide a reason for the shortage.
- Amphastar would not provide a reason for the shortage.
Estimated Resupply Dates
- APP has discontinued calcium chloride injection.
- American Regent has their product available.
- Hospira has all products available.
- Amphastar has all products available.
Related Shortages
Updated
November 3, 2008; October 6, 2008; October 1, 2008; June 30, 2008; May 28, 2008; April 23, 2008; March 19, 2008; December 5, 2007; October 23, 2007; October 3, 2007; September 17, 2007; August 27, 2007; August 16, 2007; July 25, 2007; June 14, 2007; May 17, 2007; April 17, 2007; April 3, 2007; March 23, 2007; March 22, 2007; March 5, 2007; March 2, 2007; February 23, 2007; February 16, 2007; August 22, 2006; July 10, 2006; June 14, 2006; University of Utah, Drug Information Service
Back to Drug Shortage Product Bulletins